ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,177
Screening encounters
4,975
Diagnostic referrals
948
Outstanding pathways
327

Screening pathway

  1. Screening4,975Encounters
  2. Positive finding1,720Documented findings
  3. Referral948Diagnostic referrals
  4. Follow-up1,134Diagnostic visits
  5. Outcome621Resolved pathways

Stage totals use different units. Pending pathways: 327. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2248 · EXP-2248Synthetic · Site B

Full participant history through 2027-01-21, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA technically uninterpretable · Inadequate
  3. · Repeat plan · VIA · Inadequate result · Scheduled for 2025-09-25
  4. · Screening · VIA · Repeat · Inadequate result
  5. · Screening result · VIA · VIA positive · Adequate
  6. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-05-23
  7. · Diagnostic referral · EXP-2248-T-R
  8. · Contact attempt · Unsuccessful
  9. · Diagnostic booking · Initial booking
  10. · Contact attempt · Reached
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · High-grade lesion
  14. · Follow-up disposition · Resolved · EXP-2248-T-R
  15. · Treatment · Synthetic precancer treatment
  16. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2027-02-16
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4177 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2339 · Expanded synthetic participant 2339Site E — Resource-Constrained Navigation Programme
EXP-2340 · Expanded synthetic participant 2340Site B — Peri-Urban Access Programme
EXP-2341 · Expanded synthetic participant 2341Site A — Urban Referral Hub
EXP-2342 · Expanded synthetic participant 2342Site A — Urban Referral Hub
EXP-2345 · Expanded synthetic participant 2345Site C — Rural Outreach Programme
EXP-2346 · Expanded synthetic participant 2346Site A — Urban Referral Hub
EXP-2347 · Expanded synthetic participant 2347Site B — Peri-Urban Access Programme
EXP-2348 · Expanded synthetic participant 2348Site B — Peri-Urban Access Programme
EXP-2349 · Expanded synthetic participant 2349Site A — Urban Referral Hub
EXP-2350 · Expanded synthetic participant 2350Site C — Rural Outreach Programme
EXP-2351 · Expanded synthetic participant 2351Site E — Resource-Constrained Navigation Programme
EXP-2352 · Expanded synthetic participant 2352Site D — Community Engagement Programme
EXP-2354 · Expanded synthetic participant 2354Site A — Urban Referral Hub
EXP-2355 · Expanded synthetic participant 2355Site A — Urban Referral Hub
EXP-2356 · Expanded synthetic participant 2356Site A — Urban Referral Hub
EXP-2357 · Expanded synthetic participant 2357Site B — Peri-Urban Access Programme
EXP-2358 · Expanded synthetic participant 2358Site A — Urban Referral Hub
EXP-2359 · Expanded synthetic participant 2359Site E — Resource-Constrained Navigation Programme
EXP-2360 · Expanded synthetic participant 2360Site A — Urban Referral Hub
EXP-2361 · Expanded synthetic participant 2361Site D — Community Engagement Programme
EXP-2362 · Expanded synthetic participant 2362Site A — Urban Referral Hub
EXP-2363 · Expanded synthetic participant 2363Site C — Rural Outreach Programme
EXP-2364 · Expanded synthetic participant 2364Site E — Resource-Constrained Navigation Programme
EXP-2365 · Expanded synthetic participant 2365Site A — Urban Referral Hub
EXP-2366 · Expanded synthetic participant 2366Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1889
HPV DNA
2389
Cytology
697

Navigation activity

Barrier documented
853
Contact attempt
1382
Navigation intervention
373
Diagnostic booking
1180
Diagnostic visit
1134

Documented barriers

Contact difficulty
275
Transport difficulty
280
Appointment coordination
298

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.